Phase II study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer.
Cui, Lin
Phase II study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer. [electronic resource] - Asian Pacific journal of cancer prevention : APJCP 2014 - 1699-702 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
2476-762X
10.7314/apjcp.2014.15.4.1699 doi
Adult
Aged
Carcinoma, Non-Small-Cell Lung--drug therapy
Chemoradiotherapy
Combined Modality Therapy
Disease-Free Survival
Dose Fractionation, Radiation
Drug Administration Schedule
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Paclitaxel--adverse effects
Radiotherapy, Conformal
Survival Rate
Phase II study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer. [electronic resource] - Asian Pacific journal of cancer prevention : APJCP 2014 - 1699-702 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
2476-762X
10.7314/apjcp.2014.15.4.1699 doi
Adult
Aged
Carcinoma, Non-Small-Cell Lung--drug therapy
Chemoradiotherapy
Combined Modality Therapy
Disease-Free Survival
Dose Fractionation, Radiation
Drug Administration Schedule
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Paclitaxel--adverse effects
Radiotherapy, Conformal
Survival Rate